NEHI: Medication adherence needs better coordination among stakeholders
Pharma industry serves best as underwriter of healthcare providers' efforts
The success in getting patients on therapy, and keeping them there for chronic conditions, is a well-known goal of both the biopharma industry and of healthcare providers and payers; better adherence is a win-win all around in better care and lower overall costs. Now, in a recently released study and an educational session held on Capitol Hill on March 1, NEHI (formerly known as the New England Healthcare Institute; nehi.net), a private-public policy consortium, is saying “the table is set” for managing better programs. Effective technologies and processes are becoming known, and the Patient Protection and Affordable Care Act is putting medication adherence on the priority list of quality measures by which providers will be evaluated.
“Efforts such as medical homes, the ability to review all the medications a patient is on through the electronic health record (EHR) data, and funding for medication therapy management (MTM) by pharmacists show great promise,” says Tom Hubbard, senior policy director at NEHI. “Now the challenge is to connect these pieces in a coordinated manner.”
NEHI’s report, “Roadmap to Improved Patient Medication Adherence,” is available at NEHI’s website. The Capitol Hill session was held, in part, to support legislative efforts by Senator Kay Hagan’s (D-NC) bill, “Medication Therapy Improvement Act of 2011,” (S.274), currently in committee. Hubbard says that next steps by NEHI will be to develop policy guidelines for care coordination.